Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical MPFF cream for pain after excisional haemorrhoidectomy
ACTRN12625001130459Phase 2Not yet recruiting
- Sponsor
- The University of Auckland
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of micronized purified flavonoid fraction, metronidazole and lidocaine in hemorrhoid (2 arms), sponsored by The University of Auckland. Primary endpoint: Postoperative pain level. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
micronized purified flavonoid fractionmetronidazolelidocaine
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on ACTRN12625001130459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001130459.